The repression of aroP expression which is mediated by the TyrR protein with phenylalanine, tyrosine, or tryptophan has been shown to be primarily a direct result of TyrR-mediated activation of a divergent promoter, P3, which directs the RNA polymerase away from promoter P1. Evidence which has been presented to support this conclusion is as follows. Repression of P1 does not occur either in vitro or in vivo if wild-type TyrR protein is substituted by the activation-negative mutant RQ10 (with an R-to-Q change at position 10). Repression of P1 is greatly diminished if the P3 promoter is inactivated or if a 5-bp insertion is made between the P3 promoter and the binding sites for TyrR. Repression is also abolished if the promoter strength of P1 is increased or a putative UP element associated with P3 is altered. Repression of the second promoter, P2, still occurs if the wild-type TyrR protein is substituted with RQ10 or EQ274. The tryptophan-mediated repression of aroP does not involve the TrpR protein.
Expression of the aroP gene of Escherichia coli K-12 is derepressed in tyrR strains and repressed in tyrR ϩ strains when they are grown in the presence of phenylalanine, tyrosine, or tryptophan. As indicated in the accompanying paper (24) , this makes aroP a member of the TyrR regulon. However, aroP is unusual in that it is the only member of the regulon to show a marked repression in response to the addition of phenylalanine to the medium. Although aroG, the gene for 3-deoxy-Darabinoheptulosonic acid 7-phosphate (DAHP) synthase (phe), has been reported to be repressed by TyrR protein in the presence of phenylalanine (2, 3) , studies of the aroG promoter have shown that TyrR protein alone is the major cause of aroG repression (2) . On the other hand, the expression of two genes of the TyrR regulon, mtr and tyrP, is induced or activated by TyrR protein in the presence of phenylalanine (1, 22, 23) . Both in vitro and in vivo experiments have shown that phenylalanine is essential for activation to occur. Expression of aroP is also repressed to some extent by the amino acid tryptophan. Two other genes of the TyrR regulon, aroL and mtr, are repressed by tryptophan, but in both cases repression has been shown to involve the TrpR protein (7, 12, 22) . In the case of aroL, TrpR-tryptophan-mediated repression is dependent on a functional TyrR protein (7, 12) , but in the case of mtr, it is independent of TyrR (22) . In trpR strains, however, in which tryptophan-mediated repression of mtr cannot happen, it has been shown that tryptophan can act as a cofactor with TyrR protein to activate expression of mtr (23) .
Another unusual feature of aroP regulation is that although it involves two adjacent TyrR boxes, as is the case for all members of the regulon that are repressed by tyrosine, the TyrR boxes of aroP are not positioned to overlap the putative RNA polymerase binding site of the principal promoter P1 (4, 24) but are downstream from and outside this binding site. As reported in the accompanying paper (24) , although there is a second promoter, P2, whose RNA polymerase binding site does overlap the TyrR boxes, this promoter does not appear to be the major contributor to aroP expression.
Tyrosine-mediated repression has been shown to involve and to require the self-association of TyrR protein into a hexamer (26) . It has been proposed that where there are adjacent TyrR boxes with different affinities for the TyrR protein, the hexamer is able to bind to both of the boxes and causes repression, whereas the TyrR dimer can bind only to boxes with high affinity for the protein. Such boxes are frequently positioned outside the polymerase binding site (17) . A mutant TyrR protein with the amino acid substitution EQ274 (E-to-Q change at position 274) shows impaired abilities to form hexamers and to repress genes of the regulon normally repressible by tyrosine. Again, aroP behaves differently from the others in that it retains significant repression by the EQ274 mutant (11) .
The observation reported in the accompanying paper (24) that under certain conditions it was possible to demonstrate in vitro both inhibition of transcription from the principal aroP promoter P1 and simultaneous activation of transcription from a promoter (P3) on the opposite strand suggested the possibility that repression of P1 may be a consequence of activation of P3. This possibility is examined in detail in this paper.
MATERIALS AND METHODS
Bacterial strains and plasmids. All bacterial strains used in this study were derivatives of E. coli K-12. The strains and plasmids used in this study are listed in Table 1 .
Media and chemicals. The minimal medium used was prepared from halfstrength buffer 56 described by Monod et al. (15) supplemented with 0.2% glucose and appropriate growth factors. The concentrations of various growth factors and antibiotics and the sources of various chemicals used in this study were as described elsewhere (24) .
Recombinant DNA techniques and in vitro transcription. Standard recombinant DNA procedures were performed essentially as described by Sambrook et al. (20) . DNA sequences were determined by the chain termination method described by Sanger et al. (21) with T7 DNA polymerase (Pharmacia). In vitro transcription experiments were carried out as described elsewhere (24) .
Site-directed mutagenesis. Oligonucleotides were synthesized on a Pharmacia Gene Assembler Plus apparatus. In vitro mutagenesis with synthesized oligonucleotides was performed on M13tg131 derivatives containing the aroP promoteroperator region from pMU1631 by using commercially available kits (Amersham Corporation and U.S. Biochemical Corporation). Mutations were confirmed by DNA sequencing analysis.
Construction of the 5-and 10-bp insertion mutations between the TyrR boxes and the P3 promoter of aroP. Insertion mutations were constructed by sitedirected mutagenesis. The 5-bp insertion mutation (between positions ϩ22 and ϩ23 relative to the P1 transcription start site) was generated by using the oligonucleotide TTTACATCAAAGTTATCGATGAATTGTTACAAAAAG as a primer and an M13tg131 derivative which carries a fragment containing the aroP regulatory region with base changes in the P2 Ϫ35 region (TTGATC3T CAATC) as a template. The 10-bp insertion mutation was generated by using the oligonucleotide ATCAAAGAAATTATCGAGTCTCTGAATTGTTACAAA AAG as a primer and the M13tg131 derivative which carries the aroP 5-bp insertion mutation as a template.
␤-Galactosidase assay. ␤-Galactosidase activity was assayed as described by Miller (14) . Specific activity is expressed in units described in reference 14. The data are the results of at least three independent assays.
RESULTS
Abilities of different TyrR mutants to repress aroP. In order to test whether repression of P1 could be a direct consequence of activation of the divergent promoter P3, we decided to examine repression of P1 by a TyrR mutant (TyrR-RQ10) which, because of an amino acid substitution in the aminoterminal activation domain of TyrR protein, is unable to activate gene expression of either mtr or tyrP (27, 28) . This mutant, however, retains full repressing activity for a number of genes, including aroF and tyrP. In contrast, as described previously by Kwok et al. (11) , the TyrR mutant TyrR-EQ274 is unable to repress genes aroF, aroL, tyrP, and tyrB but retains a strong ability to repress aroP. We also tested the ability of this TyrR mutant to repress the expression of the P1 or P2 promoter.
First, we introduced each of the plasmids carrying the mutant tyrR alleles into host strain JP8042 (tyrR366) containing the aroP-lacZ transcriptional fusions driven by either P1 (pMU6260) or P2 (pMU6257). The strains were grown under repressing conditions (1 mM tyrosine), and the abilities of these two TyrR mutants to repress were measured by ␤-galactosidase assay. These results, along with those for mtr and aroF as described previously (11, 27) , are shown in Table 2 . The TyrR-RQ10 mutant still retains strong activity to repress transcription from P2 (16-fold) but has almost no activity to repress transcription from P1 (1.4-fold). As for TyrR-EQ274, tyrosinemediated repression of both P1 and P2 was reduced only marginally, from 25-to 18-fold and from 35-to 25-fold, respectively.
Similar results were obtained when phenylalanine was used as a cofactor, and although repression overall is less, the same trends are also seen when tryptophan is used as a cofactor (results not shown).
P1 repression results from P3 activation. The results obtained with mutants TyrR-EQ274 and TyrR-RQ10, coupled with the unusual downstream position of the TyrR boxes and the known ability of phenylalanine and TyrR protein to activate gene expression, added support to the hypothesis that repression of P1 may be the consequence of TyrR-phenylalanine (also TyrR-tyrosine or TyrR-tryptophan) facilitating the binding of RNA polymerase to the opposite-strand promoter P3 in preference to P1. The in vitro transcription results with the P3 mutants reported in the accompanying paper (24) offered further support for this hypothesis. In order to test this hypothesis in vivo, the previously described mutations affecting the Ϫ35 and Ϫ10 sequences of P3 were separately introduced into lacZ fusion plasmid pMU2385 to produce plasmids pMU6296 and pMU6297. These plasmids were transformed into the tyrR366 strain JP8042 with or without the multicopy tyrR ϩ plasmid (pMU1065) and into the haploid tyrR ϩ strain JP7740. Cultures were grown in the presence of tyrosine, and the specific activities of ␤-galactosidase were determined. The results are shown in Table 3 . It can be seen that changes to the P3 promoter reduce overall tyrosine-mediated repression of aroP from 14-fold to about 3-fold in the haploid tyrR ϩ strain and from 33-fold to about 3-to 5-fold in the multicopy tyrR ϩ strain. Similar results were obtained when phenylalanine was used as a cofactor (results not shown). Although both promoters P1 and P2 are functional in the aroP-lacZ transcription fusion used, the reduction in repression in this case can be attributed to the loss of repression of P1 rather than P2 because in vitro studies reported in the accompanying paper have indicated that these P3 mutations have no effect on repression of P2 (24) .
In the accompanying paper, we also reported the unexpected behavior of a P2 mutant in which the Ϫ10 sequence was changed from AACAAT to AACCGG. In vivo studies demonstrated that P1 repression in this mutant was reduced to about one-third of wild-type levels (24) . A possible explanation for this result is that the change of AAT to CGG affects the P3 promoter by interfering with a putative UP sequence associated with P3 and the reduction in P3 activity causes a reduction in P1 repression. This hypothesis was also tested in an in vitro transcription assay using the pDD3 template containing this P2 mutant allele (pMU6269). It can be seen in Fig. 1 that, in addition to the expected disappearance of P2 transcript, in the presence of TyrR and phenylalanine or tyrosine the activated level of P3 expression is significantly reduced and repression of P1 is diminished.
Effects of insertions between the TyrR boxes and P3 on repression of P1. Insertion of DNA between bp ϩ22 and ϩ23 relative to the P1 transcription start site should alter the spacing between the TyrR binding sites (the TyrR boxes) and the P3 RNA polymerase binding site, changing their relative positions on the face of the DNA helix. It has previously been shown that such changes dramatically alter activation of tyrP expression (1). We made two insertions, one of 5 bp which was designed to reposition these sites on different faces of the DNA helix, and the other of 10 bp which, although extending the distance between the TyrR boxes and the P3 promoter, should allow them to retain their original positions relative to each other on the face of the helix. Both of these insertion mutations were constructed on the aroP template which contained a mutation in the Ϫ35 region of the P2 promoter, so the expression of these aroP insertion mutants was totally dependent on the P1 promoter. Results of our in vivo analysis showed that in the strain containing either the haploid or the multicopy tyrR ϩ allele, the 5-bp insertion (pMU6311) caused almost total derepression of P1 expression, whereas the 10-bp insertion (pMU6312) reduced repression only by 2.5-fold (Table 4). These results support the hypothesis that the relative positions of TyrR boxes and the P3 promoter are important for repression of P1.
Failure of TyrR-RQ10 to activate P3 and repress P1 in vitro. As described above, in vivo the TyrR activation-negative mutant TyrR-RQ10 was unable to repress P1 expression. To determine if this lack of repression was caused by an inability of TyrR-RQ10 to activate P3, we repeated in vitro transcriptional Impact of a stronger P1 promoter on repression of aroP expression. As the model which is being built up appears to be one of competition between P1 and P3 for RNA polymerase binding, with TyrR protein and the aromatic amino acids tipping the balance in favor of P3, we questioned whether increasing the promoter strength of P1 would affect repression. Sitedirected mutagenesis was used to convert the Ϫ35 region of P1 into the consensus hexamer TTGACA. The resultant transcriptional lacZ fusion plasmid was designated pMU6313. When tested in the tyrR366 background, the change was seen to increase the ␤-galactosidase activity of the aroP promoter from 642 to 1,276 U. Repression of aroP-lacZ fusion carrying this strong P1 promoter was totally abolished under all conditions (Table 5) . It was also noted that the expression from this strengthened P1 promoter is independent of the presence or absence of the P1-associated UP element (pMU6314).
Role of the two TyrR boxes. Tyrosine-mediated repression of tyrP and other tyrosine-repressible genes with the exception of aroP is thought to involve hexamerization of the protein which allows it to bind to adjacent TyrR boxes. These adjacent boxes have different affinities for dimeric TyrR protein molecules and have been classified as strong and weak TyrR boxes (16, 17) . The weak box is usually the one that overlaps the RNA polymerase binding site and is unable to bind the TyrR dimer. Repression results from cooperative binding involving the binding of the hexamers to strong and weak boxes.
In the case of mtr, however, where tyrosine causes TyrRmediated activation of gene expression, the boxes are located upstream of the RNA polymerase binding site and the strong box is closer to the promoter. In this case, both tyrosine and phenylalanine activate transcription, but tyrosine is a stronger coactivator. If the upstream weak box is inactivated, phenylalanine-mediated activation is unchanged and tyrosine-mediated activation is reduced to the level observed with phenylalanine (22) . In aroP, one sees a similar relationship between the TyrR boxes and P3, and tyrosine is also a stronger cofactor of aroP repression than phenylalanine. When disabling mutations were introduced into the upstream weak box, we still observed significant repression of aroP by either phenylalanine or tyrosine (Table 6 ). In both the haploid and the multicopy tyrR ϩ strains, the effects of the mutation on tyrosine-mediated repression were more severe than on phenylalanine-mediated repression. The reduction of phenylalanine-mediated repression is about twofold, whereas the reduction of tyrosine-mediated repression is three-to fivefold (Table 6 ). On the other hand, a mutation in the strong box almost totally abolished repression (Table 6 ). We interpret these results to indicate that a dimer binding to the strong box can cause activation of P3 and hence P1 repression in response to any one of the three aromatic amino acids. In contrast, the tyrosine-mediated activation of P3 in the wild type involves stronger interactions resulting from a hexamer binding to both the strong box and the weak box. a Units are those defined by Miller (14) . The following strains were used: tyrR366, JP8042; haploid tyrR ϩ , JP7740; and multicopy tyrR ϩ , JP8042/pMU1065. MM, minimal medium; Tyr, minimal medium containing 1 mM tyrosine; Phe, minimal medium containing 1 mM phenylalanine. Values in parentheses are fold repression, i.e., the ratio of ␤-galactosidase activity in tyrR366 strain JP8042 to that in tyrR ϩ strains. b P1 mut , mutation which changes GTGCAT to TTGACA in the Ϫ35 region of the P1 promoter. c UP Ϫ , deletion mutation in the P1 upstream region. Table 3 , footnote b, for explanation of values. MM, minimal medium; Tyr, minimal medium containing 1 mM tyrosine; Phe, minimal medium containing 1 mM phenylalanine.
Is TrpR involved in the tryptophan-mediated repression of aroP?
The possible involvement of TrpR in tryptophan-mediated repression of aroP was tested by using aroP-lacZ fusions in isogenic strains that were either trpR ϩ or trpR363. In both cases, tryptophan caused approximately threefold repression which was dependent on the presence of a functional TyrR protein (data not shown). This result shows conclusively that tryptophan-mediated repression of aroP is fundamentally different from that which occurs in the case of mtr or aroL.
DISCUSSION
The data presented in this paper provide several lines of evidence which strongly support the hypothesis that TyrR represses the expression of the major aroP promoter, P1, by activating the divergent promoter P3. We have shown that (i) the TyrR activation-negative mutant TyrR-RQ10 is unable to either activate P3 or repress P1, (ii) mutations in the P3 promoter totally abolish the TyrR-mediated repression of P1, (iii) insertion of 5 bases but not 10 bases between P3 and the TyrR boxes completely destroys transcription repression of P1, and (iv) mutational changes in the UP element preceding P3 cause significant reduction in repression of P1. The conclusion that TyrR-mediated repression of P1 is a consequence of TyrRmediated activation of P3 resolves many of the unusual features of aroP repression. The position and orientation of the strong and weak TyrR boxes, the ability of TyrR-EQ274 to repress, and the contribution that each of the aromatic amino acids tyrosine, phenylalanine, and tryptophan makes to the repression of aroP are now understandable in terms of the known characteristics of TyrR protein. Repression of transcription of a promoter by switching on a divergent promoter has previously been reported (6, 10, 13, 25) . The situation which most closely approximates the aroP situation is that of crp reported by Hanamura and Aiba (6) .
Although there is apparent TyrR-mediated transcriptional activation of P3 in vitro, we were unable to demonstrate efficient transcription from P3 in the presence of TyrR and its cofactors in vivo. One possibility is that in vivo the TyrR protein forms a transcriptionally nonproductive complex with RNA polymerase bound at P3, which is sufficient to block the transcription from the P1 promoter. We are carrying out further experiments to test this possibility.
A final unresolved puzzle for P3 is that the distance between the TyrR box closer to the promoter and the putative Ϫ35 sequence of P3 is 23 bases, whereas for mtr the corresponding distance is 28 bases. When we extend the distance to 28 bases in the case of P3 by a 5-base insertion, the repression of P1 is abolished. It is assumed that this is a consequence of a loss of P3 activation. This dilemma caused by the unusual spacing between the TyrR boxes and the Ϫ35 hexamer for P3 would be resolved if the actual Ϫ35 region were 5 bp further downstream, involving the sequence TTCCGT. However, the mutational changes which destroy P3 promoter activity in vitro affect 3 bp which lie upstream of this sequence but which are the conserved nucleotides within the hexamer that we have designated the P3 Ϫ35 sequence (Table 1) . Previous in vitro studies have shown that the binding of the TyrR protein in the presence of its cofactors to the TyrR boxes of mtr results in relief of HU-or IHF-mediated inhibition of transcription (28) . For aroP, Ca 2ϩ ions, but not HU or IHF, appear to be involved in the transcriptional process (24) . Obviously, there is a major difference between the two systems, which may reflect differences in DNA topology.
In this study, we have also shown that both P1 and P3 contain functional UP elements upstream of their respective Ϫ35 regions. However, both UP elements have less of an effect than that of the E. coli rrnB P1 UP sequence (19) . This is probably due to the relatively short length of the AT stretches of the aroP P1 and P3 UP elements compared to that of the E. coli rrnB P1 UP element. Considering the nature of both the aroP P1 and P3 promoters, whose sequences deviate considerably from the promoter consensus sequence, it is reasonable to argue that the P1-and P3-associated UP elements which enhance promoter activity are part of a complex system of competition for RNA polymerase binding at P1 or P3. Such a system may have evolved in stages and is finely balanced so that the additional contribution of P3 activation by TyrR protein can push the equilibrium towards P3 occupancy and inhibition of P1 expression. This fine balance is clearly demonstrated by the finding that strengthening promoter P1 totally abolishes repression.
The regulation by TyrR of the aroP minor promoter P2 has similarities to that of the other promoters of the tyrosinerepressible genes of the TyrR regulon, in which repression is achieved through direct competition for DNA binding between the TyrR protein and RNA polymerase. However, unlike for other tyrosine-repressible promoters, the repression of P2 can be mediated by all three aromatic amino acids instead of only by tyrosine and occurs with both mutants RQ10 and EQ274. This may reflect some intrinsic structural features of the P2 promoter and/or the steric arrangement of the aroP TyrR boxes, which may result in important protein-protein interactions mediated by the aromatic amino acids. The physiological role of P2 is difficult to determine because P2 is strongly repressed by TyrR protein in the absence of added aromatic amino acids and totally repressed in their presence. The circumstances in which it could make a major contribution to repression of aroP must be rare. Contrary to the strong expression of P2 in vitro, P2 transcripts have not been detected among in vivo-generated mRNAs (unpublished results).
The results presented in this report exclude the involvement of the TrpR repressor in the tryptophan-mediated repression of aroP expression. Instead of using TrpR as a repressor, the aroP gene uses a mechanism that employs activation by the TyrR protein of a divergent promoter to repress the expression of its major promoter, P1. This system allows expansion of the cofactors that bring about TyrR-mediated repression from the principal ligand tyrosine to include phenylalanine and tryptophan. As the protein product of aroP is responsible for the transport of all three aromatic amino acids into the cells, it would be an advantage for the expression of aroP to be controlled by each of these amino acids.
